Imipenem

Imipenem

File:Imipenem.svg
Clinical data
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	IM, IV
ATC code	J01DH51 (WHO)
Pharmacokinetic data
Metabolism	Renal
Elimination half-life	60 minutes
Identifiers
IUPAC name (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]- 6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept- 2-ene-2-carboxylic acid
CAS Number	74431-23-5
PubChem CID	47317
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C12H17N3O4S
Molar mass	299.347 g/mol

WikiDoc Resources for Imipenem
Articles
Most recent articles on Imipenem Most cited articles on Imipenem Review articles on Imipenem Articles on Imipenem in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Imipenem Images of Imipenem Photos of Imipenem Podcasts & MP3s on Imipenem Videos on Imipenem
Evidence Based Medicine
Cochrane Collaboration on Imipenem Bandolier on Imipenem TRIP on Imipenem
Clinical Trials
Ongoing Trials on Imipenem at Clinical Trials.gov Trial results on Imipenem Clinical Trials on Imipenem at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Imipenem NICE Guidance on Imipenem NHS PRODIGY Guidance FDA on Imipenem CDC on Imipenem
Books
Books on Imipenem
News
Imipenem in the news Be alerted to news on Imipenem News trends on Imipenem
Commentary
Blogs on Imipenem
Definitions
Definitions of Imipenem
Patient Resources / Community
Patient resources on Imipenem Discussion groups on Imipenem Patient Handouts on Imipenem Directions to Hospitals Treating Imipenem Risk calculators and risk factors for Imipenem
Healthcare Provider Resources
Symptoms of Imipenem Causes & Risk Factors for Imipenem Diagnostic studies for Imipenem Treatment of Imipenem
Continuing Medical Education (CME)
CME Programs on Imipenem
International
Imipenem en Espanol Imipenem en Francais
Business
Imipenem in the Marketplace Patents on Imipenem
Experimental / Informatics
List of terms related to Imipenem

Imipenem is an intravenous beta-lactam antibiotic developed in 1985. Imipenem belongs to the subgroup of carbapenems. It is derived from a compound called thienamycin, which is produced by the bacteria Streptomyces cattleya. Imipenem has a broad spectrum of activity against aerobic and anaerobic Gram positive as well as Gram negative bacteria. It is particularly important for its activity against Pseudomonas aeruginosa and the Enterococcus species. It is not active against methicillin-resistant Staphylococcus aureus, however. Imipenem and other drugs in the carbapenem class are commonly referred to as "magic bullets." Their use is typically restricted in order to avoid widespread bacterial resistance.

Method of action

Imipenem acts as an antimicrobial through inhibiting cell wall synthesis of various gram-positive and gram-negative bacteria. It remains very stable in the presence of beta-lactamase (both penicillinase and cephalosporinase) produced by some bacteria, and is a strong inhibitor of beta-lactamases from some gram-negative bacteria that are resistant to most beta-lactam antibiotics.

Co-administration with cilastatin

Main article: Imipenem/cilastatin

Imipenem is rapidly degraded by the renal enzyme dehydropeptidase when administered alone, and is always co-administered with cilastatin to prevent this inactivation.

Adverse effects

Common adverse drug reactions are nausea and vomiting. People who are allergic to penicillin and other beta-lactam antibiotics should not take imipenem. Imipenem can also cause seizures.

References

^ Clissold SP, Todd PA, Campoli Richards DM. Imipenem/Cilastatin: A reivew of its anti-bacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1987; 33: 183-241.

See also

• Imipenem/cilastatin

de:Imipenem

Template:WikiDoc Sources